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Abstract
Although treatment of ischemic stroke focuses on re-establishing blood flow to 
the brain (e.g., thrombolysis), delayed reperfusion may be associated with oxida-
tive damage to brain capillary endothelial cells, resulting in cerebral bleeding and 
death (hemorrhagic transformation). The goal of this study was to define cellular 
mechanisms responsible for reperfusion injury to brain capillaries, and to provide 
a rationale for more effective treatment of stroke. Mechanisms of oxidative injury 
to cerebral capillary endothelial cells were measured in the presence and absence of 
experimental inhibitors to define the roles of transport and metabolic pathways. In 
vitro experiments provided evidence that: (1) intracellular calcium is elevated in brain 
capillary endothelial cells following simulated transient ischemia and reperfusion, 
due to reverse movement of Na/Ca exchange; (2) a simultaneous increase of calcium 
and reactive oxygen species (ROS) during re-oxygenation causes mitochondrial dys-
function, thus initiating apoptosis and loss of brain capillary integrity. In vivo studies 
showed that γ-glutamylcysteine (an antioxidant precursor of glutathione) and the 
experimental compound KB-R7943 (inhibits reverse movement of Na/Ca exchange) 
protect brain capillary endothelial cells when co-administered just before reperfusion 
following transient ischemia. The data indicate that these agents may be useful in 
preventing oxidative injury associated with thrombolysis for ischemic stroke.
Keywords: glutathione, gamma-glutamylcysteine, antioxidant, stroke, thrombolysis, 
hemorrhagic transformation
1. Introduction
Cerebrovascular stroke is a leading cause of death and disability in the world 
[1, 2]. Strokes may be ischemic or hemorrhagic, but most (ca. 85%) are due to inter-
rupted blood flow to the brain, resulting in hypoxia [2]. Thus, the treatment for 
cerebral ischemia accompanying stroke includes therapies to re-establish blood flow 
using a thrombolytic agent [3–8]. Delayed reperfusion following cerebral ischemia 
(>3–4.5 hours) may cause damage to brain capillary endothelial cells [9–11] that 
can lead to cerebral bleeding and death [12, 13], a process called reperfusion injury 
leading to hemorrhagic transformation [14, 15]. Recent evidence has verified that 
using tissue plasminogen activator (tPA) to dissolve clots is an effective treatment 
for ischemic stroke, if administered prior to the 3–4.5 hour interval [11, 16, 17]. 
However, only about 5% of patients with cerebral ischemia arrive at the hospital in 
time to be treated without causing vascular damage and cerebral hemorrhage, and 
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a significant number of eligible patients bleed anyway [18]. Thus, preventing injury 
to the cerebral vasculature when using a thrombolytic agent to induce reperfusion 
is of great importance. In this study, we provide evidence that reperfusion injury is 
associated with oxidative damage to brain capillary endothelial cells in the presence 
of elevated calcium. Furthermore, we show that the antioxidant γ-glutamylcysteine 
[19, 20] (a precursor of glutathione) together with an agent to prevent calcium 
sequestration inhibit oxidative injury to brain capillaries when co-administered 
immediately prior to inducing reperfusion for ischemic stroke.
2. Materials and methods
To understand the mechanisms responsible for reperfusion injury to cerebral 
blood vessels, pertinent transport properties were first defined in isolated plasma 
membranes derived from brain capillary endothelial cells (i.e., the blood-brain 
barrier). This was followed by examining the effects of simulated ischemia and 
reperfusion on cultured blood-brain barrier endothelial cells, and testing the utility 
of experimental drugs in preventing cellular damage. Finally, the experimental 
therapeutic approach was tested in vivo, using the middle cerebral artery occlusion 
technique in rats to simulate ischemic stroke.
2.1 In vitro studies
2.1.1 Preparation of brain capillary endothelial membrane vesicles
Brain capillary endothelial cells are polarized and possess tight junctions 
(i.e., zonula occludens) [21]. Luminal (blood-facing) and abluminal (brain-
facing) membrane vesicles were isolated from bovine brain capillary endothelial 
cells by methods that we have described in detail [10–12, 22, 23]. Briefly, cere-
bral capillaries were isolated from cow brains by homogenization, differential 
centrifugation, and separation on a column of glass beads. Following mild 
treatment with collagenase, the capillaries were further homogenized, and the 
endothelial membranes were separated in a discontinuous Ficoll gradient.
2.1.2 Transport measurements in membrane vesicles
The methods for quantifying transport measurements using membrane vesicles 
from brain capillary endothelial cells have been published by us [8, 9, 24–26]. Rates 
of substrate uptake by luminal and abluminal membrane vesicles were determined 
using radiolabeled tracers and a rapid filtration technique [27, 28].
2.1.3 Western blot analysis of membrane vesicles
NHE1 (Na/H antiporter, isoform 1) and NCX1 (Na/Ca exchanger, isoform 1) 
were identified in isolated plasma membranes from bovine brain capillary endo-
thelial cells using immunoblotting with mouse monoclonal antibodies (Chemicon) 
and horseradish peroxidase-conjugated goat anti-mouse antibody, as previously 
described [29, 30]. The bands were analyzed by laser scanning densitometry.
2.1.4 Polymerase chain reaction analysis of cerebral capillaries
After mRNA was isolated from bovine cerebral capillaries [31], first-strand 
cDNA was synthesized using oligo-dT and AMV reverse transcriptase (Promega or 
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Invitrogen), and sense and antisense primers (Sigma) were used to generate PCR 
products for NHE1, Na/K ATPase α2, and Na/K ATPase α3, as previously described 
[31, 32]. Sequencing was performed on both strands, using a commercial service. 
Quantitative Western blotting was done as previously described [30]. The bands 
were scanned and quantified using NIH Image software.
2.1.5 Culturing cerebral capillary endothelial cells
Cultured cerebral capillary endothelial cells were used as an in vitro model to 
measure the effects of simulated ischemia and reperfusion on blood-brain bar-
rier function [33–37]. The capillary endothelial cells were isolated from bovine 
brain using the method of Meresse et al. [33], or purchased from Cell Systems 
Corporation (Kirkland, Washington). Cells were grown, maintained, seeded, and 
incubated in the presence of an astrocyte conditioned medium supplemented with 
cAMP, as previously described [33–37].
2.1.6 Simulating ischemia and reperfusion using cultured cells
Cultured brain capillary endothelial cells were exposed to conditions simulat-
ing ischemia and reperfusion by incubating first at 37°C in an ischemic medium 
(without glucose, pH 6.8) equilibrated with an atmosphere of 95% N2 and 5% CO2, 
followed by simulated reperfusion in a control medium (5.6 mM glucose, pH 7.4) 
equilibrated with room air and 5% CO2 [38, 39]. To provide a constant environ-
ment, the cells were maintained in sealed chambers (Billups-Rothenberg, CA) 
pre-equilibrated to the desired atmospheric conditions [39].
2.1.7 Measuring intracellular calcium and sodium concentrations
Intracellular calcium was quantified in cultured cerebral capillary endothelial 
cells by using a fluorescent probe and confocal laser microscopy, as previously 
described by us [39]. Cells were preloaded with 5 μM Fluo-4 [39] and treated under 
conditions of ischemia and reperfusion as described above. Calcium concentra-
tion was quantified by measuring emitted fluorescence [39, 40] at a wavelength 
of 494 nm in 50 randomly chosen (computer-assisted) cells, representing each 
treatment.
Intracellular sodium in cultured cerebral capillary endothelial cells was mea-
sured as previously described by us [39]. Cells were pre-treated with Sodium Green 
(5 μM), and the fluorescent signal was quantified by fluorescence microscopy. 
Measurements were made from 50 randomly chosen cells representing each 
treatment.
2.1.8 Measuring actin stress fibers in cultured cells
Cerebral capillary endothelial cells were grown on coverslips and exposed to 
conditions simulating normoxia, ischemia, and reperfusion as described above. 
Following treatment, the monolayers were washed in phosphate buffered saline 
(pH 7.4), fixed for 5 minutes in 3.7% buffered formaldehyde at room temperature, 
and rinsed again with the buffer [41]. A mixture of phalloidin (0.05 mg/ml buffer) 
and 1% dimethyl sulfoxide was added to the cells for 40 minutes at room tempera-
ture, in a humidified chamber. Following staining, the coverslips were washed 
with buffer and mounted in a mixture of 30% glycerol in 70% buffer (vol/vol). To 
determine the effects of calcium-mediated cytoskeletal activation, the cells were 
incubated in the presence of a myosin light chain kinase inhibitor (0.1 μM, Sigma). 
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The tissue was observed and evaluated using laser confocal microscopy, at a thick-
ness of 4 microns.
2.1.9 Measuring permeability of cultured cells
To quantify functional injury to brain capillaries, 14C-sucrose permeability was 
measured across a monolayer of cerebral capillary endothelial cells [42], under 
conditions simulating ischemia and reperfusion as described above. Cyclosporin 
A (1 μM) was used as an inhibitor of the mitochondrial permeability transition 
[43, 44], to determine if this process is associated with reperfusion injury to the 
endothelium.
2.1.10 Measuring caspase activity of cultured cells
Caspase 3 activity was measured fluorometrically using an oncogene caspase-3 
activity kit, as previously described [39]. Cultured blood-brain barrier cells were 
lysed, and the lysate was added to the caspase substrate: L-aspartyl-L-glutamyl-
L-valyl-L-aspartic acid amide (DEVD) tagged with the fluorescent molecule 
7-amino-4-trifluoromethyl coumarin (AFC). Cleaved AFC was fluorescent, and 
was quantified at an excitation wavelength of 390 nm, and an emission wavelength 
of 510 nm.
2.1.11 Measuring lysis/death of cultured cells
Lactate dehydrogenase (LDH) release was used to determine cell lysis, and 
was measured colorimetrically at a wave-length of 490 nm with a commercial kit 
(Promega). The effectiveness of various antioxidants [19, 20, 45] in preventing 
cell death was tested by incubating the cells in the presence (1 mM) and absence 
of glutathione (GSH), N-acetylcysteine (NAC), and gamma-glutamylcysteine 
(γGlu-Cys).
2.2 In vivo studies
2.2.1 Middle cerebral artery occlusion
Ischemia and reperfusion were simulated in rats using the middle cerebral artery 
occlusion (MCAO) technique [46], by placing a thread in the left cerebral artery to 
reduce blood flow in the left hemisphere, and withdrawing it to re-establish circula-
tion. Briefly, adult female Long-Evans rats (250–300 g) were anesthetized with 
isoflurane (5% induction and 2% for maintenance). The pterygopalatine artery 
and branches of the carotid artery were cauterized on the left side, after which a 3 
centimeter length of 3.0 Dermalon suture (blunt tip) was introduced in a retrograde 
direction into the external carotid artery. It was advanced cranially in the internal 
carotid artery for 23 mm, as measured from the bifurcation of the common carotid 
artery. This model reduced cerebral blood flow to about 10% of control in the core 
of the ischemic area. Reperfusion was achieved by withdrawing the thread into the 
external carotid artery.
2.2.2 Measuring brain capillary mitochondrial morphology
Mitochondrial damage indicative of reperfusion injury was measured in cerebral 
capillary endothelial cells of rats exposed for 1 hour to cerebral ischemia, followed 
by 24 hours of reperfusion. Cerebral ischemia and reperfusion was accomplished 
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using the MCAO model of ischemic stroke. Stroked animals not treated with drugs 
were infused intravascularly (IV, femoral vein) with 1 ml of physiological saline 
approximately 1 minute prior to initiating reperfusion. Treated animals were 
co-administered γGlu-Cys (400 mg/kg) and KB-R7943 (10 mg/kg) IV in 1 ml of 
physiological saline 1 minute before reperfusion. The mitochondrial permeability 
transition was assessed by measuring a typical change in ultrastructural morphol-
ogy characterized by swelling [47]. Following 60 minutes of transient ischemia and 
24 hours of reperfusion, the animals were killed, and brain cortical tissue adjacent 
to the putamen was sampled and treated with a fixative and prepared for electron 
microscopy. Fixation involved 2% paraformaldehyde and 2.5% glutaraldehyde 
in phosphate buffer, and tissue blocks were osmicated, dehydrated in an ethanol 
series, cleared in propylene oxide, and embedded in Epon. Ultra-thin sections were 
stained with uranyl acetate and lead citrate, and examined on a Jeol JEM-1230 (HC) 
electron microscope. Measurements of mitochondrial cross sectional area in cere-
bral capillary endothelial cells were determined by examining electron micrographs 
and using computer-assisted morphometry. Briefly, random samples including 
blood-vessels from the outer cerebral cortical zones of the ipsilateral and contra-
lateral sides were photographed for each animal. Five random samples included 
3 blood vessels, 9 endothelial cells, and 45 mitochondria from each of 4 animals 
per treatment. These samples were measured by outlining the mitochondria with 
an electronic pen, and compiling the data with commercial stereological software 
(Neurolucida).
2.2.3 Measuring brain apoptosis
Evidence of apoptosis in the cerebral cortex of the above animals exposed to 
ischemia/reperfusion (1 hour/24 hours) was determined by using the Apop-Tag Kit 
(Oncor). Tissue sections were randomly sampled from the cortex, and prepared for 
immunocytochemistry using the Tunnel assay [48]. The number of stained nuclei 
were quantified per unit area, as determined with the Neurolucida program.
2.2.4 Measuring neurological behavior
After 1 hour of ischemia and 24 hours of reperfusion, the above animals 
were observed for obvious neurological deficits indicated by behavioral changes. 
Attention was focused on motor deficits, torticollis, and obvious paresis.
2.3 Analysis of the data
For the measurements collectively described in this study, values were expressed 
as an average ± SD or SE. Means were compared by Student’s t test, a paired t test, or 
an ANOVA, depending upon the conditions. Mean values were considered signifi-
cantly different if the probability of their being the same was 0.05 or less.
2.4 Vertebrate animals
Plasma membrane vesicles derived from cerebral capillary endothelial cells 
were isolated from cow brains obtained at a local slaughterhouse immediately after 
death. The cows were killed for food according to Federal and State laws, and not 
for the purposes of these experiments. Cultured cerebral capillary endothelial cells 
originated either from the fresh cow brains described above, or were purchased 
commercially (Cell Systems Corporation). The middle cerebral artery occlusion 
procedure in vivo was done using rats in the Blood–Brain Barrier Lab at Oregon 
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Health and Science University (OHSU), Portland, OR. OHSU is in full compliance 
with Federal and State statutes regarding the use and care of vertebrate animals in 
research. The animal care facility is AAALAC accredited, and all rat maintenance, 
treatment, recovery, and euthanasia procedures were approved for the reported 
middle cerebral artery occlusion studies.
To achieve middle cerebral artery occlusion, female Long Evans rats (250–300 
grams) were anesthetized with isoflurane inhalant (5% induction, 2% mainte-
nance). Analgesia was provided by administering butorphanol (0.05–2.0 mg/kg 
SQ ) as needed, and seizures were controlled with diazepam (5 mg/kg) if necessary. 
Animals were monitored daily by staff veterinarians. Upon completion of the 
experiments, the rats were euthanized after inhalant anesthetic induction with an 
intracardiac overdose of sodium pentobarbital, or if symptoms necessitated earlier 
sacrifice. This method of euthanasia is consistent with requirements of the Panel of 
Euthanasia of the American Veterinary Medical Association.
3. Results
3.1 Evidence for the presence of NHE1, NCX1, and Na/K ATPase
3.1.1 Sodium flux studies
22Na uptake was measured in membrane vesicles from brain capillary endothelial 
cells, and revealed both saturable and unsaturable components (Figure 1). In the 
presence of specific inhibitors, three transport pathways were found, includ-
ing: (a) a low affinity (Km = 52 mM), high capacity, dimethyl amiloride (DMA, 
100 μM) sensitive sodium carrier, indicative of Na/H antiport; (b) a high affinity 
(Km = 4.6 mM), low capacity, DMA resistant carrier; and (c) a non-specific phena-
mil inhibitable cationic channel (Kd = 1.7 μl/mg/min).
3.1.2 Immunoblotting
Immunoblotting using specific antibodies (Chemicon) to NHE1 (Na/H anti-
porter, isoform 1) and NCX1 (Na/Ca exchanger, isoform 1) revealed that both 
proteins are present in isolated luminal and abluminal membranes derived from 
Figure 1. 
Both saturable and unsaturable 22Na uptake was measured in plasma membrane vesicles derived from bovine 
brain capillary endothelial cells. A saturable component (Km = 52 mM) was dimethyl amiloride (DMA) 
sensitive (100 μM), indicative of a sodium-hydrogen ion exchanger.
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brain capillary endothelial cells. NHE1 appeared as a single band with a molecular 
weight of 106 kD. NCX1 displayed the usual two bands at 43 kD and 150 kD.
3.1.3 PCR studies
Messenger RNA was prepared from isolated bovine brain capillaries, and 
RT-PCR was performed with specific primers identifying NHE1, Na/K ATPase α2, 
and Na/K ATPase α3. The expected PCR products were found for NHE1 (Figure 2) 
and Na/K ATPase α3, and sequencing demonstrated a high level of homology to the 
human transporters (>90%). Na/K ATPase activity was previously measured by us 
in luminal and abluminal membrane vesicles derived from endothelial cells forming 
the blood-brain barrier [25]. Activity was found to be present predominantly at the 
abluminal membrane domain, and was characterized by a ouabain binding con-
stant (Kd = 25 ± 3 nM) typical of either the α2 or α3 isoform [49]. The PCR studies 
reported in the current study confirmed that it is the α3 isoform.
3.2 Evidence that Na/H exchange elevates intracellular sodium
Intracellular sodium concentration was measured in cultured bovine brain 
capillary endothelial cells exposed to conditions simulating ischemia and reperfu-
sion. Figure 3A shows that intracellular sodium was elevated (P < 0.05) during 
ischemia (120 minutes), and remained elevated during ischemia followed by 
reperfusion (90/30 minutes). Inhibiting the Na/H antiporter with 100 μM dimethyl 
amiloride (DMA) completely prevented the elevation of intracellular sodium 
observed during ischemia/reperfusion (90/30 minutes), indicating that its activity 
was responsible for the sustained increase in intracellular sodium observed during 
ischemia and reperfusion.
3.3 Evidence that Na/Ca exchange elevates intracellular calcium
Intracellular calcium was measured in cultured bovine blood-brain barrier 
cells exposed to conditions simulating ischemia and reperfusion. Figure 3B shows 
that calcium was significantly (P < 0.05) elevated during ischemia (120 minutes), 
and remained elevated during ischemia followed by reperfusion (90/30 minutes). 
Inhibition of the reverse mode of Na/Ca exchange (20 μM KB-R7943) reduced 
(P < 0.05) the level of intracellular calcium observed following reperfusion. 
Calcium uptake was also significantly inhibited with DMA (100 μM, not shown), 
indicating that both activation of Na/H antiport and reverse movement of Na/Ca 
exchange contributed to the sustained elevation of calcium.
Figure 2. 
The RT-PCR product for NHE1 was derived from bovine brain capillary endothelial cells, with a high 
homology (96.8%) for the respective isoform in human tissue.
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3.4 Evidence for calcium-mediated alteration of the cytoskeleton
Cultured blood-brain barrier endothelial cells were exposed to conditions simulat-
ing ischemia and reperfusion, as described above. Following treatment, the cytoskel-
etal component actin was stained with phalloidin (0.05 mg/ml) [41] and examined 
using confocal laser microscopy. Incubating cells for 120 minutes under control con-
ditions revealed the usual configuration of actin, which forms an organized ring of 
fibrils just inside the plasma membrane. Incubating under ischemic conditions either 
did not alter this configuration at all, or had a relatively minor effect on cytoskeletal 
arrangement. However, exposing the cells to ischemic conditions for 90 minutes, fol-
lowed by 30 minutes of control treatment (reperfusion) caused a remarkable reorga-
nization of the actin (Figure 4), which assumed the usual stress fiber configuration 
associated with damage and increased permeability characteristics [44]. An inhibitor 
of calcium activated myosin light chain kinase [50] (Sigma, 0.1 μM) prevented the 
appearance of stress fibers observed during reperfusion (Figure 4).
3.5 Evidence for alterations of permeability characteristics
Cultured cerebral capillary endothelial cells were incubated in transwells under 
conditions simulating ischemia (90 minutes) and reperfusion (30 minutes), and per-
meability properties of the endothelial barrier were measured by quantifying unidi-
rectional flux of 14C-sucrose across the endothelium [42]. Figure 5 shows that selective 
inhibition of Na/H exchange, a brain capillary endothelial carrier shown earlier to 
contribute to calcium uptake (Figure 3) and structural damage (Figure 4) during 
reperfusion, caused a significant reduction in the observed permeability to sucrose.
3.6 Evidence for mitochondrial dysfunction
Figure 6 shows that 1 μM Cyclosporin A (CsA), an inhibitor of mitochondrial 
damage and apoptosis [42, 43, 51], significantly reduced sucrose permeability across 
Figure 3. 
Simulating ischemia-reperfusion in cultured brain capillary endothelial cells resulted in a significant increase in 
intracellular sodium (panel a) during ischemia (120 minutes), that was maintained during ischemia followed by 
reperfusion (90/30 minutes). The rise observed during ischemia/reperfusion was prevented by inhibiting Na/H 
exchange (100 μM DMA). The same results were observed when measuring intracellular calcium (panel B). 
The rise in calcium during ischemia/reperfusion was significantly reduced with a specific inhibitor of the reverse 
movement of Na/Ca exchange (20 μM KB-R 7943). Intracellular calcium was also significantly reduced by 
DMA (100 μM (not shown). *P < 0.05, different from control; + P < 0.05, different from ischemia/reperfusion. 
Values are mean ± SD. Measurements are made from 50 cells randomly chosen to represent each treatment.
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brain capillary endothelial cell monolayers associated with simulated ischemia 
(90 minutes) and reperfusion (30 minutes). In addition, Figure 7 confirms that 
ischemia (30 minutes) followed by reperfusion (24 hours) greatly increased caspase 
3 activity that is typically associated with apoptosis [51], and that this was signifi-
cantly reduced with DMA (100 μM), an inhibitor of Na/H antiport and calcium 
loading (Figure 3). A specific inhibitor of caspase 3 activity (z-VAD-FMK, 10 μM) 
Figure 4. 
Cultured blood-brain barrier cells were stained for actin with phalloidin following incubation under conditions 
of ischemia and reperfusion. Normally the actin forms a concentrated ribbon inside the plasma membrane, 
and ischemia alone causes only minor changes, if any. Simulated reperfusion (30 minutes) following ischemia 
(90 minutes), however, causes a random and diffuse rearrangement of actin, termed stress fibers (reperfusion 
without inhibitor). This pattern is typical of cell damage and enhanced permeability of passive solute 
markers through tight junctions. An inhibitor of calcium-activated myosin light chain kinase (sigma, 0.1 μM) 
completely prevented the appearance of stress fibers (reperfusion with inhibitor). These are representative fields 
from 4 sets of monolayers for each treatment.
Figure 5. 
An inhibitor of Na/H antiport (100 μM DMA, R + DMA) significantly reduced the permeability (% 
of control) to 14C-sucrose across cultured brain capillary endothelial cells observed during 90 minutes 
ischemia/30 minutes reperfusion (reperfusion). *P = 0.05. Values are mean ± SD, n = 4 0bservations.
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served as an internal control. The non-mitochondrial caspase 8 pathway for apopto-
sis showed no significant response in these cells.
3.7 Evidence for the protective role of antioxidants
We have previously shown that the antioxidant γ-glutamylcysteine reduces 
injury to cultured brain capillary endothelial cells [58] under conditions of simu-
lated ischemia/reperfusion. Cells were incubated for 1.5 hours under ischemic 
conditions, followed by 3 hours of simulated reperfusion. The presence of 1 mM 
γ-glutamylcysteine significantly inhibited release of lactate dehydrogenase (LDH) 
into the incubation medium, thus reducing cell lysis. Additional new studies in 
our laboratory confirm that the antioxidants glutathione and N-acetylcysteine 
significantly (P<0.05) inhibit LDH release from cultured brain capillary endothelial 
cells under the same circumstances. Compared to cultured cells incubated under 
conditions simulating ischemia (1.5 hours) and reperfusion (3 hours) in the absence 
of these antioxidants, 1 mM glutathione and 1 mM N-acetylcysteine inhibited 
mean LDH release by factors of 0.51 and 0.45, respectively. Collectively, the data 
Figure 7. 
Caspase 3 activity was expressed in cultured blood-brain barrier cells exposed to conditions simulating 
ischemia-reperfusion. Twenty-four hours of reperfusion following 30 minutes of ischemia resulted in a large 
increase in caspase 3 activity that was inhibited with DMA (100 μM). *P < 0.05 from control; +P < 0.05 from I/
rep. I/rep is ischemia plus reperfusion; I/R Na inh is ischemia-reperfusion with DMA inhibition; I/R Cp inh is 
ischemia-reperfusion with a specific caspase inhibitor. Values are mean ± SD, n = 3 observations.
Figure 6. 
Inhibiting the mitochondrial permeability transition with Cyclosporin A (1 μM, R + CsA) significantly 
inhibited the sucrose permeability (% of control) observed during 30 minutes of reperfusion (R control), 
following 90 minutes of ischemia. *P < 0.05. Values are mean ± SD, n = 3 observations.
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indicate that injury to cultured brain capillary endothelial cells exposed to isch-
emia/reperfusion is significantly reduced in the presence of known antioxidants 
[19, 20, 45] including native glutathione, and its precursors N-acetylcysteine, and 
γ-glutamylcysteine.
3.8 In vivo evidence for a strategy to prevent reperfusion injury
The purpose of the following experiments was to confirm that the mechanisms 
revealed by our cellular and molecular studies could be used to design a therapeutic 
approach in whole animals for the treatment of reperfusion injury to the brain capil-
laries, following transient ischemic stroke. The in vitro data suggested that two key 
factors are responsible for cellular injury and disruption of brain capillaries: (1) a 
rise in intracellular calcium due to reverse movement of the Na/Ca exchanger during 
reperfusion, and (2) depletion of endogenous antioxidant activity during the pro-
longed ischemia, resulting in an elevation of reactive oxygen species upon reperfusion. 
This led to our conclusion that a reasonable treatment for damage to brain capillary 
endothelial cells following transient ischemia would be to administer an inhibitor of 
reverse movement of Na/Ca exchange to prevent the rise in intracellular calcium, and 
to buffer reactive oxygen species by restoring antioxidant activity within the cells.
To test this hypothesis, middle cerebral artery occlusion (MCAO) was per-
formed on Long-Evans female rats, involving 1 hour of ischemia to the left cerebral 
hemisphere, and 24 hours of reperfusion. One group of animals received KB-R7943 
(10 mg/kg) and γ-glutamylcysteine (400 mg/kg) in 1 ml of isotonic saline solu-
tion 1 minute prior to reperfusion (IV, femoral vein), while the other group was 
administered a placebo (isotonic saline). Following treatment, tissue from the 
lateral cortex was prepared for electron microscopy, and the cross-sectional area of 
mitochondria in blood-brain barrier endothelial cells was quantified using mor-
phometric techniques. The contralateral (right) hemisphere served as an internal 
control for non-ischemic tissue. The data is represented by electron micrographs 
in Figure 8 from 2 of 4 animals in each group. As observed in the left panels of 
Figure 8 depicting tissue exposed to ischemia/reperfusion without the drugs, 
mitochondria of blood-brain barrier endothelial cells (solid arrows) are noticeably 
swollen and abnormal in appearance, indicative of the mitochondrial permeability 
transition associated with apoptosis [43, 51]. In some instances, mitochondria have 
actually been extruded into the lumen (dashed arrows) of the capillary, indicat-
ing extensive cell damage. In the right panels showing tissue from 2 of 4 stroked 
animals administered the drugs, the mitochondria are normal, and the blood-brain 
barrier endothelial cells look healthy. When comparing the groups of animals, 
morphometric measurements of endothelial mitochondrial size revealed a highly 
significant (P = 0.0015) increase in swelling in stroked animals without the drugs 
vs. those with the drugs, expressed as a percent change in cross-sectional area from 
the control contralateral hemisphere (67 ± 15 vs. 13 ± 12, mean ± SD, n = 4 animals 
per group).
3.9 In vivo evidence for inhibition of apoptosis
Cerebral cortical tissue was randomly sampled from the animals above (1 hour 
ischemia/24 hours reperfusion), and the TUNEL assay was performed to determine 
if apoptosis was occurring. Representative tissue from 2 of 4 animals in each group 
is shown in Figure 9. The left panels show cerebral tissue from stroked animals 
without the drugs. Comparable regions are shown in the right panels, representing 
tissue from stroked animals that also received the drugs just prior to reperfusion. 
The cerebral tissue from stroked animals without the drugs showed prominent 
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nuclear staining indicative of apoptosis, both in cerebral capillaries (arrows) and 
neural tissue. A morphometric analysis of the number of stained nuclei per unit area 
for 4 animals in each group (without drugs vs. with drugs) showed a significant dif-
ference (3.16 ± 2.00 grains/mm2 vs. 0.39 ± 0.47 grains/mm2, P = 0.036). No staining 
was observed in tissue from the contralateral, unstroked cerebral hemispheres.
3.10 In vivo evidence for inhibition of neurological dysfunction
To examine the effects of the drugs on neurological behavior following isch-
emic stroke, the animals for each group above were observed following 1 hour of 
ischemia and 24 hours of reperfusion. Table 1 indicates that all 4 of the stroked 
animals without the drugs showed neurological deficits. Two additional stroked 
animals not receiving the drugs died. By contrast, 3 of 4 stroked animals that were 
given the drugs at the time of reperfusion showed no signs of neurological deficit. 
Furthermore, none of the animals receiving the drugs died.
Figure 8. 
Rats were subjected to conditions of transient ischemic stroke using middle cerebral artery occlusion for1 hour, 
followed by 24 hours of reperfusion. One group of stroked animals received cytoprotective drugs (i.e., KB-R 
7943 [10 mg/kg] and γ-glutamylcysteine [400 mg/kg]) 1 minute prior to reperfusion, and a second group 
of stroked animals were administered a placebo. Lateral cerebral cortical tissue was prepared for electron 
microscopy, and the cross-sectional area of mitochondria in cerebral capillary endothelial cells was measured 
morphometrically. Two of four stroked animals without the drugs areshown in the left panels of the figure, and 
two of four stroked animals receiving the drugs are shown in the right panels. It is apparent that mitochondria 
are swollen in cerebral capillary endothelial cells of stroked animals without the drugs (left panels, solid 
arrows), suggesting the mitochondrial permeability transition [43] associated with apoptosis [51]. In some 
cases, damaged mitochondria have been extruded into the capillary lumen (left panels, dashed arrows). By 
contrast, the mitochondria of stroked animals given the drugs appear normal (right panels). When compared 
to mitochondria of the unstroked contralateral hemisphere (internal control), the percent increase in cross-
sectional area was significantly (P = 0.0015) greater for the stroked animals not given the drugs (67 ± 15 vs. 13 ± 
12, mean ± SD, n = 4 animals per group).
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4. Discussion
The purpose of this study was to define cellular mechanisms that contribute 
to reperfusion injury of blood vessels within the brain following thrombolysis for 
ischemic stroke, and to identify pharmacological agents that may be used to prevent 
cerebral bleeding associated with thrombolytic treatment for stroke. It is known 
that administering the thrombolytic agent tPA after approximately 3–4.5 hours of 
ischemia may cause reperfusion injury to brain capillaries [9–11] that can result in 
cerebral hemorrhage and death [12, 13]. Since approximately 95% of patients with 
ischemic strokes do not reach the hospital in time to be properly evaluated and 
Figure 9. 
Brain tissue from the above rats subjected to transient ischemic stroke (1 hour ischemia/24 hours reperfusion) 
was probed for evidence of apoptosis, using the TUNEL assay. Two of four stroke animals without and with 
the cytoprotective drugs (left and right panels, respectively) are depicted. In this figure, immunocytochemical 
nuclear reactions indicative of apoptosis are clearly visible in the animals without the drugs (left panels), but 
are not observed in the animals that were given the drugs (right panels). All four stroked animals without the 
drugs demonstrated apoptosis in blood-brain barrier endothelial cells (arrows) and neural tissue. Quantifying 
the number of stained nuclei per unit area showed a significant difference between animals without and with 
the drugs (3.1 6 ± 2.00 grains/mm2 vs. 0.39 ± 0.47 grains/mm2, mean ± SD, n = 4 animals per group, P = 0.036).
Table 1. 
Neurological behavior following transient ischemic stroke.
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safely administered a thrombolytic agent [18], the possibility of cerebral hemor-
rhage severely limits the treatment of stroke with tPA.
Cerebral capillary endothelial cells represent the fundamental structure of 
the blood-brain barrier [52]. These cells are polarized, containing both luminal 
(blood-facing) and abluminal (brain-facing) plasma membranes with distinct 
properties [21–23, 25, 26, 53–56]. The cells are held together by tight junctions that 
effectively inhibit paracellular transport [21], implying that the properties of the 
respective luminal and abluminal plasma membranes regulate transport across 
the blood-brain barrier. Based upon observations in other tissues [40, 57], we 
hypothesized that ischemia-reperfusion injury to cerebral capillary endothelial cells 
is due to oxidative injury associated with the formation of reactive oxygen species 
in the presence of elevated intracellular calcium during reperfusion [58–62]. This 
would require loss of intracellular antioxidant (e.g., glutathione) during prolonged 
ischemia, formation of free reactive oxygen species and uptake of calcium dur-
ing re-oxygenation, and damage to mitochondria causing programmed cell death 
(apoptosis).
To test this hypothesis, we began by determining if the cellular processes 
required for these mechanisms are functional in blood-brain barrier endothelial 
cells. We reasoned that intracellular glutathione, an endogenous antioxidant, would 
diffuse out of the cells during ischemia, utilizing passive carriers we had previously 
described on both plasma membranes [58]. We next provided evidence that both 
Na/H (NHE1) and Na/Ca (NCX 1) exchangers are present on the plasma membrane 
domains of these cells, and that conditions simulating ischemia and reperfusion 
result in elevated intracellular calcium due to activation of sodium-hydrogen ion 
antiport and reverse movement of sodium-calcium exchange (Figure 3). Cellular 
lysis following these events was significantly inhibited by adding the antioxidant 
γGlu-Cys [19, 20, 58], which is consistent with the formation of reactive oxygen 
species expected upon re-oxygenation in glutathione depleted cells. These findings 
reinforced our interpretation that a combination of elevated intracellular calcium 
and reactive oxygen species are involved in injury to cerebral capillary endothelial 
cells, under conditions of ischemia and reperfusion.
Our studies further indicated that injury to brain capillaries involves two phases. 
An early increase in permeability to sucrose (Figure 5), a marker of paracellular 
transport, was associated with the formation of actin stress fibers inside the endo-
thelial cells (Figure 4). This was, in turn, accompanied by the appearance of large 
intercellular holes (Figure 4), apparently due to the opening of tight junctions 
[63]. We reasoned that such a change could be due to activation of myosin light 
chain kinase in the presence of the elevated intracellular calcium that we previously 
observed (Figure 3). Since it has been shown that ischemia causes actin filaments to 
conjugate with ZO-1 [64], a tight junctional protein, force generated by contraction 
of the cytoskeleton could weaken the tight junctions and result in the formation of 
stress fibers. Indeed, treatment with a myosin light chain kinase inhibitor effectively 
reversed the effects of simulated ischemia and reperfusion on the formation of actin 
stress fibers, and the appearance of large intercellular holes (Figure 4). These mor-
phological and functional changes in cerebral capillary endothelial cells occurred 
within a few hours of exposure to conditions simulating ischemia and reperfusion, 
and generally correlated with an early and reversible phase of altered permeability 
to the cerebral vasculature when exposed to conditions of ischemia and reperfusion 
in vivo [64].
A second phase of injury to cerebral capillaries following transient ischemia 
and reperfusion involved apoptosis and endothelial cell death. In an initial set of 
experiments, sucrose permeability was measured across monolayers of cultured 
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blood-brain barrier endothelial cells exposed to conditions simulating ischemia 
and reperfusion. Permeability was significantly reduced by co-incubating with 
cyclosporin A (Figure 6), an inhibitor of the mitochondrial permeability transition 
associated with the early stages of apoptosis [42, 43, 51]. Under similar conditions, 
cultured blood-brain barrier endothelial cells expressed a large increase in caspase 
3 activity after 24 hours of simulated reperfusion following ischemia (Figure 7), 
indicating activation of the apoptotic pathway [51].
These in vitro findings were consistent with our working hypothesis which 
predicted that elevated intracellular calcium and reactive oxygen species would 
activate apoptosis in cerebral capillary endothelial cells exposed to conditions of 
ischemia and reperfusion. Furthermore, the results suggested that: (1) inhibiting 
reverse movement of Na/Ca exchange with KB-R7943 [65], and (2) replenishing 
lost antioxidant with γGlu-Cys [19, 20] would prevent reperfusion (oxidative) 
injury to brain capillaries. Since γGlu-Cys is a precursor of the antioxidant glutathi-
one [59] lost during ischemia, and γGlu-Cys itself possesses antioxidant properties 
[19, 20], it represents a reasonable antioxidant therapeutic in this setting.
The next logical step was to determine if drugs that prevent increased levels 
of intracellular calcium and reactive oxygen species in brain capillary endothelial 
cells would inhibit damage to cerebral capillaries in vivo. Thus, rats were exposed 
to middle cerebral artery occlusion to simulate ischemic stroke, after which the 
animals were either treated with a placebo (isotonic saline), or administered a com-
bination of γGlu-Cys (400 mg/kg) and KB-R7943 (10 mg/kg) in isotonic saline that 
was infused intravenously approximately 1 minute prior to initiating reperfusion of 
cerebral blood flow. The rationale was that administering the combination of drugs 
immediately before re-establishing cerebral blood flow would protect the endothe-
lial cells of cerebral capillaries from oxidative injury upon reperfusion. Figure 8 
indeed illustrates that such a therapeutic approach significantly inhibited mor-
phological damage to cerebral capillary endothelial cells, including swelling of the 
mitochondria that is indicative of oxidative injury and the permeability transition 
that precedes apoptosis [51, 61, 62]. Furthermore, the Tunnel assay revealed that 
co-infusion of the drugs immediately before reperfusion inhibited the appearance 
of apoptosis in representative cerebral cortical tissue 24 hours after re-establishing 
blood flow to the brain (Figure 9). Finally, an assessment of neurological behavior 
confirmed that use of the drugs inhibited functional damage due to ischemia and 
reperfusion (Table 1).
5. Conclusions
Together these studies support the interpretation that prolonged cerebral ischemia 
followed by reperfusion of oxygenated blood may cause oxidative damage to cerebral 
capillary endothelial cells consistent with loss of vascular integrity and hemorrhage. 
The mechanisms involve mitochondrial injury and apoptosis due to the formation of 
reactive oxygen species in the presence of elevated cellular calcium. This condition 
may be treated by using the antioxidant γGlu-Cys to buffer reactive oxygen species, 
and a Na/Ca inhibitor (reverse mode) to prevent calcium loading in cerebral capil-
lary endothelial cells. The in vivo studies indicate that co-administering both drugs 
intravascularly 1 minute prior to reperfusion provides cytoprotection that reduces 
reperfusion injury to the cerebral vasculature. Thus, this may represent a means of 
prolonging the window of opportunity to use a thrombolytic agent for treatment 
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